Hims & Hers Joins the Super Bowl Advertising Lineup
The Super Bowl, a stage for the biggest moments in advertising, witnessed a new player enter the game this year: Hims & Hers. With millions of eyes on the Super Bowl, Hims & Hers seized the moment to bring the conversation about accessible weight loss to a national stage. During the third quarter of Super Bowl LVIII, the digital health company aired its first-ever Super Bowl commercial, focusing on a topic increasingly relevant in today’s society: accessible and affordable GLP-1 weight loss treatments.
The ad marks a major move for Hims & Hers. It highlights their commitment to addressing the growing demand for effective weight management solutions. This increased visibility also shines a light on the broader landscape of GLP-1 treatments, where companies like Zappy Health are already making significant strides in providing accessible and cost-effective alternatives.
The Growing Demand for GLP-1 Medications
The U.S. obesity crisis is at an all-time high, with 42% of adults classified as obese according to the CDC’s latest report. Research has also shown that obesity-related conditions contribute to an estimated 280,000 to 300,000 preventable deaths annually in the U.S.
As a result, the popularity of GLP-1 medications—originally designed for diabetes but widely used for weight loss—has skyrocketed. GLP-1 (glucagon-like peptide-1) medications work by mimicking a hormone that helps regulate blood sugar and reduce appetite, making them highly effective for weight loss. However, access remains a challenge. Brand-name GLP-1 treatments like Wegovy cost over a thousand dollars monthly. Only a few individuals can access these life-changing treatments. Even worse, supply shortages have created frustration among patients seeking long-term weight loss solutions.
Hims & Hers aims to address this gap by offering compounded GLP-1 medications as a more accessible alternative. But Zappy Health has taken affordability a step further. The company now provides a wider range of treatment options and even more competitive pricing, ensuring that cost isn’t a barrier to weight loss success.
The Message Behind the Super Bowl Ad
Hims Super Bowl ad, titled “Sick of the System,” directly tackles the frustrations many feel with the current weight loss industry. It criticizes the $160 billion industry and its focus on profit over patient well-being. It further argues that obesity is not simply a matter of individual willpower, but rather a consequence of a flawed healthcare system that often prioritizes high drug prices and promotes unhealthy food consumption.
While Hims & Hers’ ad raises important points about the challenges of accessing affordable weight loss treatments, Zappy Health has already been actively addressing these issues with proven solutions and competitive pricing. Unlike a marketing campaign, Zappy Health’s commitment to affordability and accessibility is already making a tangible impact. With real patient success stories, flexible pricing models, and dedicated medical support, Zappy Health offers more than just an alternative—it provides a proven solution.
Affordable Weight Loss Solutions: How Zappy Health Outperforms Hims & Hers
Hims & Hers offers its compounded semaglutide injections starting at $199/mo and all the way up to $399/mo. They are manufactured in the U.S. and come with doctor-designed weight loss plans for patients interested in personalized treatments. This is significantly cheaper than brand-name options, such as Wegovy, which costs $1,249. However, Hims limits the dose to around 1 mg, significantly lower than the recommended highest dose of 2.4 mg, which means patients will not be able to maximize their weight loss potential.
However, Zappy Health offers an even more compelling value proposition in several key areas:
- More competitive pricing—offering lower-cost GLP-1 treatment options
- A wider range of tailored treatment plans based on individual health needs
- Stronger medical supervision with personalized weight loss guidance
- No limits on the dose, with the same price applying to the highest dose of 2.4 mg.
Unlike Hims & Hers, Zappy Health’s treatment plans are designed with your unique health needs in mind, ensuring a tailored approach for sustainable weight loss success.
For individuals looking for sustainable, affordable, and GLP-1 weight loss treatments, Zappy Health remains the superior choice.
Super Bowl as a Platform for GLP-1 Awareness
Hims & Hers’ investment of an estimated $7 million per 30-second Super Bowl slot demonstrates its commitment to entering the GLP-1 market. Over the 2024-2025 NFL season, ads for weight loss drugs like Ozempic and Wegovy have accounted for some of the best Super Bowl commercials 2024, reflecting the increasing mainstream demand for GLP-1 treatments.
This increased visibility greatly benefits Hims & Hers and helps to educate the public about science-backed weight loss solutions. But that’s not all. It also shifts more attention to alternatives like Zappy Health, which offers greater affordability, flexibility, and personalized care.
The Competitive Landscape and the Future of Weight Loss Treatments
As demand for GLP-1 medications grows, pharmaceutical giants like Novo Nordisk (Wegovy, Ozempic) and Eli Lilly (Zepbound) continue to dominate the market. This has also sparked regulatory discussions about safety, efficacy, and affordability. For example, in 2024, Hims & Hers introduced a GLP-1 tracker to help patients monitor medication availability amid supply chain disruptions.
Meanwhile, Zappy Health is taking a proactive approach, ensuring consistent access to high-quality, affordable GLP-1 treatments while prioritizing patient outcomes. As competition in the weight loss sector intensifies, Zappy Health continues to lead with exceptional results tailored specifically to individuals at transparent and affordable rates.
A Milestone Moment for Hims & Hers, but Zappy Health Leads the Charge
Hims & Hers’ Super Bowl campaign marks a significant milestone in the company’s ambition to become a leader in the weight loss sector. The brand’s commitment to providing affordable GLP-1 access is a step forward in addressing the obesity epidemic.
However, Zappy Health has already established itself as the leader in providing cost-effective, doctor-supervised GLP-1 treatments. With lower prices, personalized plans, and proven results, Zappy Health isn’t just shaping the future of weight loss—it’s actively making it more accessible today.
As the conversation around GLP-1 medications grows, the real question isn’t just about affordability—it’s about access and real results. Zappy Health delivers both. If you’re ready to start your weight loss journey with a trusted, affordable provider, visit Zappy Health today and see how our personalized plans can help you achieve real results.
